|
ES2654143T3
(es)
|
2012-10-02 |
2018-02-12 |
Gilead Sciences, Inc. |
Inhibidores de desmetilasas de histonas
|
|
US9243022B2
(en)
|
2012-12-21 |
2016-01-26 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
CA2895808A1
(en)
|
2012-12-21 |
2014-06-26 |
Quanticel Pharmaceuticals, Inc. |
Histone demethylase inhibitors
|
|
SG10201707027SA
(en)
|
2013-02-27 |
2017-09-28 |
Epitherapeutics Aps |
Inhibitors of histone demethylases
|
|
JP6294953B2
(ja)
|
2013-03-14 |
2018-03-14 |
ヤンセン ファーマシューティカ エヌ．ベー． |
Ｐ２ｘ７調節物質
|
|
JO3509B1
(ar)
|
2013-03-14 |
2020-07-05 |
Janssen Pharmaceutica Nv |
معدلات p2x7
|
|
ES2689526T3
(es)
|
2013-03-14 |
2018-11-14 |
Janssen Pharmaceutica Nv |
Moduladores de P2X7
|
|
TWI599567B
(zh)
|
2013-03-14 |
2017-09-21 |
健生藥品公司 |
Ｐ２ｘ７調節劑
|
|
EA029052B1
(ru)
|
2013-03-14 |
2018-02-28 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Замещенные (бензилцианометил)амиды 2-азабицикло[2.2.1]гептан-3-карбоновых кислот в качестве ингибиторов катепсина с
|
|
KR102359214B1
(ko)
|
2014-04-04 |
2022-02-07 |
델 마 파마슈티컬스 |
폐의 비소세포 암종 및 난소암을 치료하기 위한 디안하이드로갈락티톨 및 이의 유사체 또는 유도체
|
|
CN106660982B
(zh)
*
|
2014-06-25 |
2020-09-08 |
赛尔基因昆蒂赛尔研究公司 |
组蛋白脱甲基酶抑制剂
|
|
JP2017526675A
(ja)
|
2014-08-27 |
2017-09-14 |
ギリアード サイエンシーズ， インコーポレイテッド |
ヒストンデメチラーゼを阻害するための化合物および方法
|
|
WO2016039977A1
(en)
|
2014-09-12 |
2016-03-17 |
Janssen Pharmaceutica Nv |
P2x7 modulators
|
|
AU2015315693B2
(en)
|
2014-09-12 |
2020-01-16 |
Janssen Pharmaceutica Nv |
P2X7 modulating n-acyl-triazolopyrazines
|
|
HUE047208T2
(hu)
|
2014-09-12 |
2020-04-28 |
Boehringer Ingelheim Int |
A katepszin-C spirociklikus inhibitorai
|
|
US10030017B2
(en)
|
2014-09-17 |
2018-07-24 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
|
SG11201702147TA
(en)
|
2014-09-17 |
2017-04-27 |
Celgene Quanticel Res Inc |
Histone demethylase inhibitors
|
|
EP3397617A4
(en)
*
|
2015-12-28 |
2019-05-22 |
Celgene Quanticel Research, Inc. |
HISTONDEMETHYLASEINHIBITOREN
|
|
WO2017161012A1
(en)
*
|
2016-03-15 |
2017-09-21 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
|
KR101725292B1
(ko)
|
2016-03-30 |
2017-04-10 |
한국과학기술연구원 |
항암 활성을 갖는 신규 피리미딘-4-카르복시산 유도체
|
|
US10150754B2
(en)
|
2016-04-19 |
2018-12-11 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
|
WO2017198785A1
(en)
*
|
2016-05-18 |
2017-11-23 |
Ieo - Istituto Europeo Di Oncologia S.R.L. |
Oxime derivatives useful as inhibitors of histone demethylase kdm4c
|
|
BR102017010009A2
(pt)
|
2016-05-27 |
2017-12-12 |
Gilead Sciences, Inc. |
Compounds for the treatment of hepatitis b virus infection
|
|
ES2969239T3
(es)
|
2016-05-27 |
2024-05-17 |
Gilead Sciences Inc |
Combinación de ledipasvir y sofosbuvir para su uso en el tratamiento de infecciones por el virus de la hepatitis B en humanos
|
|
JOP20190024A1
(ar)
|
2016-08-26 |
2019-02-19 |
Gilead Sciences Inc |
مركبات بيروليزين بها استبدال واستخداماتها
|
|
SI3507276T1
(sl)
|
2016-09-02 |
2022-01-31 |
Gilead Sciences, Inc. |
Spojine modulatorja toličnih receptorjev
|
|
WO2018045150A1
(en)
|
2016-09-02 |
2018-03-08 |
Gilead Sciences, Inc. |
4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
|
|
KR20230010826A
(ko)
|
2016-10-14 |
2023-01-19 |
프리시젼 바이오사이언시스 인코포레이티드 |
B형 간염 바이러스 게놈 내의 인식 서열에 대해 특이적인 조작된 메가뉴클레아제
|
|
TWI714820B
(zh)
|
2017-01-31 |
2021-01-01 |
美商基利科學股份有限公司 |
替諾福韋艾拉酚胺(tenofovir alafenamide)之晶型
|
|
UY37581A
(es)
|
2017-02-02 |
2018-08-31 |
Gilead Sciences Inc |
Compuestos para el tratamiento de la infección por virus de la hepatitis b
|
|
ES2991090T3
(es)
|
2017-03-30 |
2024-12-02 |
Univ Freiburg Albert Ludwigs |
Inhibidores de KDM4
|
|
BR102018007822A2
(pt)
|
2017-04-20 |
2018-11-06 |
Gilead Sciences, Inc. |
composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
|
|
UY37774A
(es)
*
|
2017-06-19 |
2019-01-31 |
Novartis Ag |
Compuestos 5-cianoindol sustituidos y usos de los mismos
|
|
US11203610B2
(en)
|
2017-12-20 |
2021-12-21 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2′3′ cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
|
JP7037667B2
(ja)
|
2017-12-20 |
2022-03-16 |
インスティチュート オブ オーガニック ケミストリー アンド バイオケミストリー エーエスシーアール，ヴイ．ヴイ．アイ． |
Ｓｔｉｎｇアダプタータンパク質を活性化するホスホン酸結合を有する３’３’環状ジヌクレオチド
|
|
WO2019160882A1
(en)
|
2018-02-13 |
2019-08-22 |
Gilead Sciences, Inc. |
Pd-1/pd-l1 inhibitors
|
|
JP7050165B2
(ja)
|
2018-02-26 |
2022-04-07 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｈｂｖ複製阻害剤としての置換ピロリジン化合物
|
|
WO2019195181A1
(en)
|
2018-04-05 |
2019-10-10 |
Gilead Sciences, Inc. |
Antibodies and fragments thereof that bind hepatitis b virus protein x
|
|
TW202005654A
(zh)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
２，２，─環二核苷酸
|
|
TWI818007B
(zh)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-環二核苷酸
|
|
TWI833744B
(zh)
|
2018-04-06 |
2024-03-01 |
捷克科學院有機化學與生物化學研究所 |
3'3'-環二核苷酸
|
|
US11142750B2
(en)
|
2018-04-12 |
2021-10-12 |
Precision Biosciences, Inc. |
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
|
|
KR102591947B1
(ko)
|
2018-04-19 |
2023-10-25 |
길리애드 사이언시즈, 인코포레이티드 |
Pd-1/pd-l1 억제제
|
|
WO2019211799A1
(en)
|
2018-05-03 |
2019-11-07 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide
|
|
PE20210642A1
(es)
|
2018-07-13 |
2021-03-23 |
Gilead Sciences Inc |
Inhibidores de pd-1/pd-l1
|
|
WO2020028097A1
(en)
|
2018-08-01 |
2020-02-06 |
Gilead Sciences, Inc. |
Solid forms of (r)-11-(methoxymethyl)-12-(3-methoxypropoxy)-3,3-dimethyl-8-0x0-2,3,8,13b-tetrahydro-1h-pyrido[2,1-a]pyrrolo[1,2-c] phthalazine-7-c arboxylic acid
|
|
MA53721A
(fr)
|
2018-09-28 |
2021-09-15 |
Janssen Pharmaceutica Nv |
Modulateurs de la monoacylglycérol lipase
|
|
JP7413368B2
(ja)
|
2018-09-28 |
2024-01-15 |
ヤンセン ファーマシューティカ エヌ．ベー． |
モノアシルグリセロールリパーゼ調節因子
|
|
US11236085B2
(en)
|
2018-10-24 |
2022-02-01 |
Gilead Sciences, Inc. |
PD-1/PD-L1 inhibitors
|
|
EP3873608A1
(en)
|
2018-10-31 |
2021-09-08 |
Gilead Sciences, Inc. |
Substituted 6-azabenzimidazole compounds having hpk1 inhibitory activity
|
|
EP4371987B9
(en)
|
2018-10-31 |
2025-11-26 |
Gilead Sciences, Inc. |
Substituted 6-azabenzimidazole compounds as hpk1 inhibitors
|
|
WO2020178768A1
(en)
|
2019-03-07 |
2020-09-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
|
WO2020178769A1
(en)
|
2019-03-07 |
2020-09-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotides and prodrugs thereof
|
|
CN113574063B
(zh)
|
2019-03-07 |
2025-03-18 |
捷克共和国有机化学与生物化学研究所 |
3’3’-环二核苷酸及其前药
|
|
TW202210480A
(zh)
|
2019-04-17 |
2022-03-16 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TWI751517B
(zh)
|
2019-04-17 |
2022-01-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
US11453681B2
(en)
|
2019-05-23 |
2022-09-27 |
Gilead Sciences, Inc. |
Substituted eneoxindoles and uses thereof
|
|
CN114245807B
(zh)
|
2019-06-25 |
2025-05-02 |
吉利德科学公司 |
Flt3l-fc融合蛋白和使用方法
|
|
WO2021011891A1
(en)
|
2019-07-18 |
2021-01-21 |
Gilead Sciences, Inc. |
Long-acting formulations of tenofovir alafenamide
|
|
US20220296619A1
(en)
|
2019-08-19 |
2022-09-22 |
Gilead Sciences, Inc. |
Pharmaceutical formulations of tenofovir alafenamide
|
|
CA3156100A1
(en)
|
2019-09-30 |
2021-04-08 |
Janssen Pharmaceutica Nv |
Radiolabelled mgl pet ligands
|
|
HRP20241379T1
(hr)
|
2019-09-30 |
2024-12-20 |
Gilead Sciences, Inc. |
Cjepiva za hbv i postupci za liječenje hbv
|
|
US12410418B2
(en)
|
2019-12-06 |
2025-09-09 |
Precision Biosciences, Inc. |
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
|
|
KR102987126B1
(ko)
|
2020-03-20 |
2026-07-07 |
길리애드 사이언시즈, 인코포레이티드 |
4'-c-치환된-2-할로-2'-데옥시아데노신 뉴클레오시드의 프로드러그 및 이의 제조 및 사용 방법
|
|
CA3176946A1
(en)
|
2020-03-26 |
2021-09-30 |
Janssen Pharmaceutica Nv |
Monoacylglycerol lipase modulators
|
|
LT4192474T
(lt)
|
2020-08-07 |
2025-11-25 |
|
Fosfonamidų nukleotidų analogų provaistai ir jų farmacinis panaudojimas
|
|
TWI815194B
(zh)
|
2020-10-22 |
2023-09-11 |
美商基利科學股份有限公司 |
介白素2-Fc融合蛋白及使用方法
|
|
US20240269142A1
(en)
|
2021-05-13 |
2024-08-15 |
Gilead Sciences, Inc. |
COMBINATION OF A TLR8 MODULATING COMPOUND AND ANTI-HBV siRNA THERAPEUTICS
|
|
JP7651018B2
(ja)
|
2021-06-23 |
2025-03-25 |
ギリアード サイエンシーズ， インコーポレイテッド |
ジアシルグリセロールキナーゼ調節化合物
|
|
MX2023014762A
(es)
|
2021-06-23 |
2024-01-15 |
Gilead Sciences Inc |
Compuestos moduladores de diacilglicerol quinasa.
|
|
EP4359413A1
(en)
|
2021-06-23 |
2024-05-01 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
CN117355531A
(zh)
|
2021-06-23 |
2024-01-05 |
吉利德科学公司 |
二酰基甘油激酶调节化合物
|
|
CN114907318B
(zh)
*
|
2022-07-04 |
2023-08-11 |
郑州大学 |
一种异烟酸-吡唑衍生物及其制备方法和应用
|
|
EP4750773A1
(en)
*
|
2023-07-27 |
2026-06-03 |
Beone Medicines I GmbH |
Quinoline derivatives and pharmarceutical compositions thereof for the treatment of disease
|
|
WO2025240246A1
(en)
|
2024-05-13 |
2025-11-20 |
Gilead Sciences, Inc. |
Combination therapies with ribavirin
|
|
US20250345390A1
(en)
|
2024-05-13 |
2025-11-13 |
Gilead Sciences, Inc. |
Combination therapies
|
|
TW202608468A
(zh)
|
2024-05-13 |
2026-03-01 |
美商基利科學股份有限公司 |
組合療法
|
|
WO2025240242A1
(en)
|
2024-05-13 |
2025-11-20 |
Gilead Sciences, Inc. |
Combination therapies with ribavirin
|